Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01963065 · ClinicalTrials.gov registry record
NICU-HEALTH (Hospital Exposures and Long-Term Health)
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 239
- Enrollment target
NCT01963065: Completed study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT01963065 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 239 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01963065 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 239 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the impact of environmental exposures during the NICU hospitalization on preterm infant development. The research team is interested in both chemical and non-chemical exposures. Research studies have shown that babies are exposed to plasticizers (bisphenol A, phthalates) in the NICU. Plasticizers are chemicals that are used to make plastic medical equipment soft and flexible. The research team wants to find out whether NICU-based exposure to chemicals (including common plasticizers) and other non-chemical exposures like stress makes a difference to how they grow and develop.
Primary Outcome
Performance on a scale of newborn neurodevelopment designed both for use in newborns exposed to toxins in utero and for evaluation of infants born preterm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 239 participants |
| Start Date | 2015-03-01 |
| Est. Completion | 2020-04-28 |
What the finished NCT01963065 record still lists
NCT01963065 is an observational study that tracks outcomes without assigning an intervention. The registered 239 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01963065 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01963065 about?
NCT01963065 is a clinical study titled "NICU-HEALTH (Hospital Exposures and Long-Term Health)". The purpose of this study is to evaluate the impact of environmental exposures during the NICU hospitalization on preterm infant development. The research team is interested in both chemical and non-chemical exposures. Research studies have shown that babies are exposed to plasticizers (bisphenol A,...
What is the current status of trial NCT01963065?
This trial is currently completed. The enrollment target is 239 participants. The study started on 2015-03-01. Estimated completion is 2020-04-28.
Who is sponsoring clinical trial NCT01963065?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI